NCT05312710 2026-01-16Safety and Efficacy of APG-157 in Head and Neck CancerAveta Biomics, Inc.Phase 2 Active not recruiting24 enrolled
NCT03254927 2023-04-03A Study of CDX-3379 and Cetuximab and in Patients With Advanced Head and Neck Squamous Cell CarcinomaCelldex TherapeuticsPhase 2 Terminated30 enrolled 17 charts
NCT00210470 2020-12-11A Phase 2 Clinical Trial of the Safety and Effects of IRX-2 in Treating Patients With Operable Head and Neck CancerBrooklyn ImmunoTherapeutics, LLCPhase 2 Completed27 enrolled 16 charts
NCT00272181 2015-12-23Study of Proxinium for Treating Patients With Squamous Cell Head and Neck CancerSesen Bio, Inc.Phase 2 Terminated15 enrolled